Stéphane Bancel, CEO of Moderna: "We are working on a preventive vaccine against cancer caused by Lynch syndrome"

Stéphane Bancel, CEO of Moderna, discusses the company's advancements in cancer vaccines and other infectious disease projects. The mRNA-4157 vaccine shows a 42% improvement in melanoma treatment compared to standard options. Despite data leaks before the ESMO conference, Bancel remains optimistic about future approvals and ongoing research, including a preventive vaccine for Lynch syndrome and combined vaccines for flu and COVID-19. Moderna is also exploring solutions for Lyme disease and Epstein-Barr virus, while facing challenges with HIV vaccine development.